Evaluate Efficacy and Safety of LACUDY for Improving Vaginal Environment in Breast Cancer Patient

Launched by GUN OH CHONG · Dec 6, 2022

Keywords

ClinConnect Summary

* Registered subjects are 1:1 randomized using a random sequencing generator (www.random.org). Experimental group with 30 patients and Control group with 30 patinets.
* In the case of the experimental group, LACUDY 2mL is inserted twice a week for a month before going to bed for 4 weeks.

* Unpack the product and take it out.
* Remove the cap by turning it.
* Fit the nozzle to the end of the syringe and turn it to combine.
* Hold the syringe with the nozzle facing the vulva, insert it about 5-6 cm into the vagina, and then slowly press the tip of the push rod with patient's thumb to...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Female
• • 2. Aged 20 to 60 years diagnosed with breast cancer
• • 3. Receiving anti-hormonal therapy
• • 4. Patients who subjectively complain of vaginal dryness
• • 5. Patients without current psychiatric problems
• • 6. Patients who can understand and respond to the contents of the questionnaire
• • 7. Ability to provide informed consent
• Exclusion Criteria:
• • 1. Women under 19 and over 61
• • 2. Pregnant woman
• • 3. In case of recurrence or disease progression
• • 4. Patients without sexual experience
• • 5. Unable to provide informed consent